IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,459,000 | -31.5% | 25,809 | -42.5% | 0.01% | -38.5% |
| Q3 2020 | $2,131,000 | -6.0% | 44,919 | +16.8% | 0.01% | -7.1% |
| Q2 2020 | $2,267,000 | -36.7% | 38,449 | -49.2% | 0.01% | -46.2% |
| Q1 2020 | $3,581,000 | -73.1% | 75,733 | -63.5% | 0.03% | -71.4% |
| Q2 2019 | $13,319,000 | -20.9% | 207,238 | -0.2% | 0.09% | -19.5% |
| Q1 2019 | $16,848,000 | +50.1% | 207,565 | 0.0% | 0.11% | +34.5% |
| Q4 2018 | $11,221,000 | +8.2% | 207,565 | +3.3% | 0.08% | +47.4% |
| Q3 2018 | $10,366,000 | +19.4% | 200,977 | -3.6% | 0.06% | +11.8% |
| Q2 2018 | $8,684,000 | -7.3% | 208,405 | -1.9% | 0.05% | -10.5% |
| Q1 2018 | $9,364,000 | -12.8% | 212,425 | -0.5% | 0.06% | -6.6% |
| Q4 2017 | $10,740,000 | +2.4% | 213,524 | +3.3% | 0.06% | +8.9% |
| Q3 2017 | $10,484,000 | +2.9% | 206,784 | +3.3% | 0.06% | -1.8% |
| Q2 2017 | $10,187,000 | – | 200,258 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |